Nano-X Imaging faces a precarious financial outlook as its transition to a hardware-as-a-service model struggles to overcome significant structural cost burdens. While the company achieved a 24.0% year-over-year revenue increase in 2025Q4, the persistent negat...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 9, 2026 | -$0.79-387.6% vs -$0.16 | $4M-22.7% vs $5M |
Q3 2026 Jun 25, 2026 | -$0.20-42.9% vs -$0.14 | $4M-29.5% vs $6M |
Q2 2026 Apr 20, 2026 | -$0.50-117.4% vs -$0.23 | $4M-12.5% vs $4M |
Q4 2025 Nov 20, 2025 | -$0.21+1.6% vs -$0.21 | $3M-1.6% vs $4M |
Shares of Nano-X Imaging Ltd. (NASDAQ: NNOX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, two have assigned a buy rating and
Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd.
Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript
Nano-X Imaging NASDAQ: NNOX reported second-quarter 2026 revenue growth driven by its teleradiology, health IT and AI businesses, while recording a substantial non-cash impairment charge and outlining cost-reduction actions intended to extend its cash runway.
Benchmark NNOX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Nano-X Imaging Ltd. (NNOX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.70 | $48.57M | -0.60 | 15.4% | -576.13% | -45.62% | — | |
| $1.70 | $22.4M | -2.91 | 35.27% | -13.06% | -1.89% | — | |
| $10.03 | $1.54B | -10.45 | 24.95% | -13.5% | -818.99% | — | |
| $18.09 | $1.03B | -10.52 | 37.22% | -32.54% | -30.62% | — | |
| $66.09 | $29.85B | 14.53 | 4.84% | 7.86% | 14.91% | — | |
| $273.40 | $104.81B | 32.55 | 11.16% | 14.43% | 16.36% | — |
Nano-X Imaging Ltd. (NNOX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when NNOX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Nano-X Imaging Ltd. (NNOX) stock FAQ — growth, dividends, profitability & financials explained
Nano-X Imaging Ltd. (NNOX) reported $15.6M in revenue for fiscal year 2025.
Nano-X Imaging Ltd. (NNOX) grew revenue by 15.4% over the past year. This is strong growth.
Nano-X Imaging Ltd. (NNOX) reported a net loss of $116.8M for fiscal year 2025.
Nano-X Imaging Ltd. (NNOX) has a return on equity (ROE) of -45.6%. Negative ROE indicates the company is unprofitable.
Nano-X Imaging Ltd. (NNOX) had negative free cash flow of $53.3M in fiscal year 2025, likely due to heavy capital investments.
